BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM –

Study Design
The study period started on August 6, 2021, which was 7 days after the approval of the booster for use in persons 60 years of age or older in Israel. The study period ended on September… [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *